Outpatient oral anticoagulant management - An audit of 82 patients

Journal of Association of Physicians of India

Volumn 53, Issue OCT., 2005, Pages 847-852

  Kakkar, N ^a   Kaur, R ^a   John, Mary ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; ARTICLE; DRUG MONITORING; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; INDIA; MALE; MEDICAL AUDIT; MIDDLE AGED; ORAL DRUG ADMINISTRATION; RETROSPECTIVE STUDY; STANDARD;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AMBULATORY CARE; ANTICOAGULANTS; DRUG MONITORING; FEMALE; HUMANS; INDIA; MALE; MEDICAL AUDIT; MIDDLE AGED; RETROSPECTIVE STUDIES; THROMBOLYTIC THERAPY;

EID: 26044441256     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Shetty HG. Routledge PA. Optimising the dose of oral anticoagulants. Ann Acad Med Singapore 1991;20:161-4.
2. Berrettini M. Anticoagulation clinics: the Italian experience. Haematologica 1997;82:713-7.
3. Hirch J, Poller L. The International Normalized Ratio. Arch Intern Med 1994;154:288-92.
4. Nichols WL, Bowie EJ. Standardization of the prothrombin time for monitoring orally administered anticoagulant therapy with use of the international normalized ratio system. Mayo Clin Proc 1993;68:897-8.
5. Haemostasis and Thrombosis Task Force for the British Committee for Standards in Haematology. Guidelines on oral anticoagulation: Third edition. Br J Haematol 1998;101:374-87.
6. Froom P, Miron E, Barak M. Oral anticoagulants in the elderly. Br J Haematol 2003;120:526-8.
7. Kagansky N, Knobler H, Rimon E, Ozer Z, Levy S. Safety of anticoagulation therapy in well-informed older patients. Ann Intern Med 2004;164:2044-50.
8. Chow WH, Chow TC, Tse TM, Tai YT, Lee WT. Anticoagulation instability with life-threatening complication after dietary modification. Postgrad Med J 1990;66:855-7.
9. Wittlowsky Ak, Boccuzzi SJ, Wogen J, Wygant G, Patel P, Haunch O. Frequency of concurrent use of warfarin with potentially interacting drugs. Pharmacotherapy 2004;24:1668-74.
10. Tan G, Cohen H, Taylor F, Gabbay J. Audit of start of anticoagulation treatment in inpatients. J Clin Pathol 1993;46:67-71.
11. Azar AJ, Deckers JW, Rosendaal FR, van Bergen PF, van der Meer FJ, Jonker JJ, et al. Assessment of therapeutic quality control in a long-term anticoagulant trial in post-myocardial infarction patients. Thromb Haemost 1994 ;72:347-51.
12. Rose P. Audit of anticoagulant therapy. J Clin Pathol 1996;49:5-9.
13. McCormick D, Gurwitz JH, Goldberg RJ, Becker R, Tate JP, Elwell A, et al. Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting. Arch Intern Med 2001;161:2458-63.
14. de Vicente Camara MP, Lucia Cuesta JF, Aguilar Franco C, Solano Bernad V, Serrano Gonzalez, Garcia-Erce JA. Sangre 1999;44:469-72.
15. Alonso Roca R, Puche Lopez N, de la Fuente Arriaran MD, Serrano Santos P, Garcia Monterrubio L. Therapeutic quality control of follow-up of oral anticoagulation in primary care: 4-year experience. Aten Primaria 1995;15:555-60.
16. Christensen TD. Self-management of oral anticoagulant therapy: a review. J Thromb Thrombolysis 2004;18:127-43.
17. Goldberg Y, Meytes D, Shabtai E, Shinron O, Shainberg B, Seligsohn U, Berliner S. Monitoring oral anticoagulant therapy by telephone communication. Blood Coagul Fibrinolysis 2005;16:227-30.
18. Bharat V, Das NK, Mohanty B, Jha AC, Chawla SC, Dash B et al. Reduction of mechanical heart valve thrombosis through a clinical audit. J Heart Valve Dis 2003;12:362-9.